Access your linked article here:


Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (ABRAXANE) with Anti-Angiogenic Agent
TO EXPLORE NEWSRX SOLUTIONS, CLICK HERE:
Financial

Asset Managers

Corporate Finance

Hedge Funds

Private Equity

Traders

Wealth Managers

Knowledgeable
  Consumers

 Healthcare

Clinicians

Employers

Government

Health Plans

Hospital / Provider

Pharmaceuticals

Knowledgeable
  Consumers

 Scientific

Academics

Engineers

Librarians/Educators

Researchers

Scientists

Journalists

Knowledgeable
  Consumers

 Technology

Computer Designers

Software Programmers

Network Engineers

Communications Engrs.

Internet / intranet Engrs.

Artificial Intelligence

Knowledgeable
  Consumers

 Legal/Regulatory

Government

Attorneys

Law Firm Managers

Litigators

Librarians / Educators

Academics

Knowledgeable
  Consumers

 Business

Accountants / Auditors

Librarians / Educators

Media

Marketers

PR Firms

Information Analysts

Knowledgeable
  Consumers